TG Therapeutics, Inc. (TGTX)
29.59
-0.16
(-0.54%)
USD |
NASDAQ |
Dec 31, 10:40
TG Therapeutics Market Cap: 4.698B for Dec. 31, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Amgen, Inc. | 176.26B |
| Karyopharm Therapeutics, Inc. | 125.67M |
| Axsome Therapeutics, Inc. | 8.885B |
| Krystal Biotech, Inc. | 7.166B |
| Arcutis Biotherapeutics, Inc. | 3.554B |
Market Cap Related Metrics
| PE Ratio | 10.65 |
| PS Ratio | 8.992 |
| Price to Book Value | 7.736 |
| Price | 29.59 |
| Earnings Yield | 9.39% |
| Operating PE Ratio | 46.54 |
| Normalized PE Ratio | 10.65 |